Pembroke Management LTD raised its stake in shares of Acadia Healthcare Company, Inc. (NASDAQ:ACHC) by 0.1% during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 397,445 shares of the company’s stock after buying an additional 200 shares during the period. Acadia Healthcare accounts for 1.7% of Pembroke Management LTD’s portfolio, making the stock its 23rd largest position. Pembroke Management LTD owned approximately 0.45% of Acadia Healthcare worth $19,625,000 as of its most recent filing with the SEC.
A number of other hedge funds have also added to or reduced their stakes in ACHC. Emerald Mutual Fund Advisers Trust acquired a new stake in Acadia Healthcare during the first quarter valued at $210,000. Paloma Partners Management Co acquired a new stake in Acadia Healthcare during the first quarter valued at $217,000. M&T Bank Corp acquired a new stake in Acadia Healthcare during the first quarter valued at $230,000. Teacher Retirement System of Texas acquired a new stake in Acadia Healthcare during the first quarter valued at $258,000. Finally, Benjamin F. Edwards & Company Inc. raised its stake in Acadia Healthcare by 224.2% in the first quarter. Benjamin F. Edwards & Company Inc. now owns 6,290 shares of the company’s stock valued at $274,000 after buying an additional 4,350 shares during the period.
Acadia Healthcare Company, Inc. (ACHC) opened at 52.17 on Tuesday. The firm has a market capitalization of $4.58 billion, a price-to-earnings ratio of 573.30 and a beta of 1.15. Acadia Healthcare Company, Inc. has a 1-year low of $32.54 and a 1-year high of $54.34. The company has a 50 day moving average price of $50.42 and a 200-day moving average price of $44.84.
Acadia Healthcare (NASDAQ:ACHC) last issued its earnings results on Thursday, July 27th. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.65 by $0.01. The company had revenue of $715.90 million during the quarter, compared to analysts’ expectations of $717.38 million. Acadia Healthcare had a return on equity of 8.69% and a net margin of 0.30%. Acadia Healthcare’s quarterly revenue was down 5.4% compared to the same quarter last year. During the same period in the prior year, the business posted $0.73 EPS. On average, analysts forecast that Acadia Healthcare Company, Inc. will post $2.45 EPS for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: This article was reported by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this article on another website, it was stolen and republished in violation of U.S. & international copyright & trademark legislation. The legal version of this article can be accessed at https://stocknewstimes.com/2017/08/15/pembroke-management-ltd-acquires-200-shares-of-acadia-healthcare-company-inc-nasdaqachc-updated-updated.html.
ACHC has been the topic of a number of recent research reports. Leerink Swann lowered Acadia Healthcare from an “outperform” rating to a “market perform” rating in a research note on Monday, May 15th. Jefferies Group LLC set a $55.00 price target on Acadia Healthcare and gave the company a “buy” rating in a research note on Thursday, June 1st. William Blair initiated coverage on Acadia Healthcare in a research note on Tuesday, July 18th. They set an “outperform” rating on the stock. Zacks Investment Research raised Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, April 28th. Finally, KeyCorp reissued an “overweight” rating and set a $51.00 price target on shares of Acadia Healthcare in a research note on Thursday, June 1st. Five research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock has an average rating of “Buy” and a consensus price target of $59.21.
In other Acadia Healthcare news, Director Reeve B. Waud sold 50,000 shares of the stock in a transaction that occurred on Friday, June 9th. The stock was sold at an average price of $45.09, for a total value of $2,254,500.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director William Grieco sold 2,000 shares of the stock in a transaction that occurred on Friday, June 16th. The stock was sold at an average price of $45.42, for a total value of $90,840.00. Following the completion of the sale, the director now owns 47,013 shares of the company’s stock, valued at approximately $2,135,330.46. The disclosure for this sale can be found here. Insiders have sold a total of 2,138,347 shares of company stock valued at $105,486,669 over the last 90 days. 11.10% of the stock is currently owned by company insiders.
About Acadia Healthcare
Acadia Healthcare Company, Inc is a provider of behavioral healthcare services, with operations in the United States and the United Kingdom. The Company focuses on acquiring and developing behavioral healthcare facilities. The Company operates through two segments: U.S. Facilities and U.K. Facilities.
Receive News & Ratings for Acadia Healthcare Company Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare Company Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
